Reduced bone formation in non-steroid treated patients with rheumatoid arthritis.
AUTOR(ES)
Compston, J E
RESUMO
The cellular basis of trabecular bone loss in rheumatoid arthritis was investigated in 45 non-steroid treated patients. Mean wall thickness, an indicator of the amount of bone formed per remodelling unit, mean interstitial bone thickness, which is related to resorption depth, and the extent of trabecular surface covered by osteoid, which reflects the number of remodelling units, were assessed in iliac crest biopsy specimens. The mean wall thickness was significantly reduced in the patient group when compared with controls matched for age and sex (mean (SD) 39.8 (5.4) v 51.6 (9.7) microns). There was no significant difference between patients and controls in the mean interstitial bone thickness (51.0 (26.4) v 61.4 (31.9) microns) or osteoid surface (16.7 (11.4) v 21.0 (10.5)%). These results show that reduced bone formation at the remodelling unit level is the predominant mechanism of bone loss in rheumatoid arthritis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003792Documentos Relacionados
- Bone turnover in non-steroid treated rheumatoid arthritis.
- Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis.
- Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis.
- Long term follow up of spinal trabecular bone mineral density in women with non-steroid treated rheumatoid arthritis.
- Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis.